Market Overview

UPDATE: Oppenheimer Upgrades EZchip Semiconductor to Outperform on Favorable Risk/Reward

Related EZCH
EZchip Falls On Lowered Sales Forecast; Durata Therapeutics Shares Jump
Midday Losers From October 6 - GT Advanced Technologies Inc, Tekmira Pharmaceuticals Corporation And More

Oppenheimer upgraded EZchip Semiconductor (NASDAQ: EZCH) from Perform to Outperform and announced a $31.00 price target.

Oppenheimer noted, "We are upgrading EZCH based on much-improved risk-reward, following a 21% selloff Wednesday. We believe the sell-off is overdone and exaggerates the impact of management's reduced long-term revenue target. Despite lower guidance, EZCH still offers attractive investment potential for 1) expanding edge router market and rising customer traction; 2) high margin/leverage operating model; and 3) $6 cash per share."

EZchip Semiconductor closed at $25.56 on Wednesday.

Latest Ratings for EZCH

DateFirmActionFromTo
Oct 2014Feltl & Co.DowngradesStrong BuyBuy
Aug 2014Imperial CapitalInitiates Coverage onOutperform
Jun 2014Feltl & Co.UpgradesBuyStrong Buy

View More Analyst Ratings for EZCH
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Upgrades Analyst Ratings

 

Related Articles (EZCH)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional